You are here: Home » Companies » News
Business Standard

Ranbaxy accused of gaming FDA rules to thwart rivals

Bloomberg  |  New York 

Ranbaxy Laboratories Ltd was accused in a lawsuit of conspiring with a web of lawyers and consultants to manipulate the US Food and Drug Administration (FDA) and block competition in the generic drug business. Ranbaxy for years filed false or incomplete paperwork with the FDA to win 180 days of marketing exclusivity for generic drugs that the Gurgaon, India-based company wasn't ready to make, according to a complaint filed Tuesday in a Boston federal court. The proposed class action was brought by Michigan retailer Meijer Inc. and its distribution arm. They are seeking to represent ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Thu, May 14 2015. 00:40 IST